CRISPR-Cas9 Genome Editing: Mechanism & Applications

Added:

Limitations of Double-Stranded Breaks and the Shift to Precision Editing Alternatives

While CRISPR-Cas9 is celebrated for its gene-cutting abilities, a major critical perspective in genomic science focuses on the biological risks of introducing double-stranded DNA breaks (DSBs). When CRISPR-Cas9 cleaves DNA, the cell's error-prone natural repair mechanisms can cause unintended large deletions, insertions, or chromosomal rearrangements. Furthermore, inducing DSBs can trigger a p53-mediated DNA damage response, which may kill healthy cells or inadvertently select for cancer-prone cells. Additionally, 'off-target' effects remain a persistent concern, where the system cuts unintended genomic sites. Because of these safety risks and unpredictable outcomes, many scientists advocate for newer alternatives like Base Editing and Prime Editing. These next-generation technologies allow for precise, single-nucleotide alterations or search-and-replace editing without severing the DNA backbone, offering a safer and more controlled pathway for therapeutic applications.

The structure of DNA and the rules of complementary base pairing (A-T, C-G).
The Central Dogma of Molecular Biology, specifically how DNA is transcribed into RNA and translated into proteins.
The nature of genetic mutations and how alterations in the genetic code can lead to inherited diseases.
The cell's endogenous DNA repair pathways, specifically Non-Homologous End Joining (NHEJ) and Homology-Directed Repair (HDR).
Advanced gene-editing technologies that build upon CRISPR-Cas9, such as base editors and prime editors.
In vivo and ex vivo delivery systems for CRISPR components, including viral vectors and lipid nanoparticles (LNPs).
The ethical, legal, and societal implications (ELSI) of germline versus somatic gene editing in humans.
Current clinical breakthroughs, active clinical trials, and real-world therapeutic applications of CRISPR (e.g., sickle cell disease treatments).
The mechanism and ecological consequences of 'gene drives' to control vector-borne diseases or invasive species.
4.4M views42.3Klikes4:13@McGovernInstituteOriginal Release: 2014-11-05

CRISPR-Cas9 is a revolutionary genome editing technology derived from a bacterial immune system that enables precise modification of DNA sequences in living cells; it works by using a guide RNA to direct the Cas9 enzyme to a specific location in the genome, where it creates a double-strand break that the cell attempts to repair, allowing researchers to introduce targeted mutations, replace defective genes with healthy copies, or study gene function with unprecedented precision and efficiency across diverse applications including biomedical research, agriculture, and potential human genetic disease treatment.